OpenMedicare
Start Here
Explore
Fraud
Investigations
Data
Tools
About

Footer

OpenMedicare

Independent Medicare data journalism

Sister Sites

  • OpenMedicaid
  • OpenFeds
  • OpenSpending

Explore

  • Providers
  • Procedures
  • States
  • Specialties
  • Search

Fraud Analysis

  • Still Out There (AI)
  • Fraud Overview
  • Fraud Watchlist
  • Deep Dive Profiles
  • Impossible Numbers
  • Report Fraud

Investigations

  • The Algorithm Knows
  • How We Built the Model
  • Internal Medicine Crisis
  • Florida & California Fraud
  • Million Dollar Flagged
  • All Investigations

Tools

  • Provider Lookup
  • Compare
  • Cost Calculator
  • Your Medicare Dollar
  • Downloads

About

  • About OpenMedicare
  • Methodology
  • Glossary
  • Data Sources
  • API Docs
  • Updates
Data Sources: Centers for Medicare & Medicaid Services (CMS), Medicare Provider Utilization and Payment Data
Disclaimer: This site is an independent journalism project. Data analysis and editorial content are not affiliated with or endorsed by CMS or any government agency. All spending figures are based on publicly available Medicare payment records.
Sister Sites: OpenMedicaid ยท OpenFeds ยท OpenSpending

ยฉ 2026 OpenMedicare. Independent data journalism. Built by TheDataProject.ai

Methodologyโ€ขDownload Data
  1. Home
  2. Providers
  3. Christopher Paris
๐Ÿ‘๏ธ
MDIndividual

Christopher Paris, MD

NPI: 1679561815
Billings, MT
10 years of data
Ophthalmology
$7.9M
Total Payments
12.6K
Beneficiaries
66.0K
Services
1.97x
Markup Ratio

Peer Comparison

98th
percentile in specialty
This provider$7.9M
Specialty median$383.7K

๐Ÿ“‹ Key Findings

1Billed $7.9M over 10 years
21.97x markup ratio
398th percentile in Ophthalmology by payments
41 procedure with >3x markup
โœ“ No flags detected

๐Ÿ”Ž Data Analysis

This provider's $7.9M in total Medicare payments ranks in the 98th percentile of Ophthalmology providers nationally.

This provider's billing patterns fall within normal ranges for their specialty.

AI-generated analysis based on Medicare payment data.

Annual Medicare Payments

Annual Services Provided

Avg Payment per Service

Markup Ratio Over Time

Submitted Charges vs. Medicare Payments

Average per-service amounts submitted by the provider compared to what Medicare actually paid โ€” the gap represents the markup.

YearAvg SubmittedAvg PaidMarkup RatioGap per ServiceTotal PaymentsServicesBeneficiaries
2014$284.39$172.381.65x$112.01$723.1K8.0K1.7K
2015$291.70$174.721.67x$116.98$792.9K8.4K1.7K
2016$323.02$198.391.63x$124.63$859.8K7.8K1.5K
2017$308.76$192.131.61x$116.63$903.0K7.5K1.4K
2018$308.75$186.671.65x$122.08$933.8K7.0K1.3K
2019$326.64$196.611.66x$130.03$968.5K6.7K1.2K
2020$327.36$193.511.69x$133.85$852.9K5.9K1.0K
2021$311.92$182.261.71x$129.66$825.6K5.5K1.0K
2022$273.65$154.951.77x$118.70$692.9K4.9K908
2023$273.82$151.181.81x$122.64$382.7K4.4K896

Top Procedures (11)

J0178Injection, aflibercept, 1 mg
$4.1M
5.5K services$749.75/svc1.33x markup
67028Injection of drug into eyeโš  4.3x markup
$1.2M
15.3K services$80.38/svc4.25x markup
92012Eye and medical examination for diagnosis and treatment, established patient
$1.1M
17.6K services$63.60/svc2.06x markup
92134Diagnostic imaging of retina
$544.6K
17.4K services$31.26/svc2.37x markup
J2778Injection, ranibizumab, 0.1 mg
$439.7K
1.5K services$299.50/svc1.40x markup
J9035Injection, bevacizumab, 10 mg
$403.5K
7.6K services$53.29/svc1.41x markup
92004Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits
$56.0K
519 services$107.88/svc2.13x markup
J2777Injection, faricimab-svoa, 0.1 mg
$15.7K
538 services$29.13/svc1.61x markup
92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits
$9.3K
96 services$97.19/svc1.98x markup
99214Established patient office or other outpatient, visit typically 25 minutes
$1.6K
20 services$78.95/svc2.23x markup
99213Established patient office or other outpatient visit, typically 15 minutes
$576.10
11 services$52.37/svc2.18x markup
Show detailed table โ–พ
CodeDescriptionServicesPaymentsAvg/ServiceMarkup
J0178Injection, aflibercept, 1 mg5.5K$4.1M$749.751.33x
67028Injection of drug into eye15.3K$1.2M$80.384.25x
92012Eye and medical examination for diagnosis and treatment, established patient17.6K$1.1M$63.602.06x
92134Diagnostic imaging of retina17.4K$544.6K$31.262.37x
J2778Injection, ranibizumab, 0.1 mg1.5K$439.7K$299.501.40x
J9035Injection, bevacizumab, 10 mg7.6K$403.5K$53.291.41x
92004Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits519$56.0K$107.882.13x
J2777Injection, faricimab-svoa, 0.1 mg538$15.7K$29.131.61x
92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits96$9.3K$97.191.98x
99214Established patient office or other outpatient, visit typically 25 minutes20$1.6K$78.952.23x
99213Established patient office or other outpatient visit, typically 15 minutes11$576.10$52.372.18x

Markup Analysis

Charge-to-Payment Ratio

1.97x

This provider submits charges 1.97 times higher than what Medicare actually pays.

What This Means

A markup ratio of 1.97x means for every $100 Medicare pays, this provider initially charges $197. This is lower than the national average.

Location

Billings, MT

Provider Verification

Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.

Related

Browse
โ† Back to Provider Directory
State
All providers in MT โ†’
Specialty
All Ophthalmology providers โ†’
Tool
Compare this provider โ†’
Analysis
Fraud Watchlist โ†’
Search
Search all providers โ†’

Share This Provider

Share this provider's Medicare payment information

Share:

Data Sources

  • โ€ข Centers for Medicare & Medicaid Services (CMS)
  • โ€ข Medicare Provider Utilization and Payment Data (2014-2023)
  • โ€ข National Plan and Provider Enumeration System (NPPES)

Last Updated: February 2026 (data through 2023, the latest CMS release)

Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.

Believe this data is inaccurate? Dispute this data